Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age

Clinical trial NCT05301322 · COMPLETED

Trial details

NCT number: NCT05301322
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Syncytial Virus

Start date: 2022-04-13
Primary completion: 2022-10-12
Enrollment: 1471

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.